Research Article

Polymorphisms of the DNA Methyltransferase 1 Gene Predict Survival of Gastric Cancer Patients Receiving Tumorectomy

Table 2

Associations between the SNPs and clinical parameters of gastric cancer patients.

rs10420321rs16999593rs2228612rs2228611rs2288349
AAAG + GGTTTC + CCTTTC + CCGGGA + AAGGGA + AA

130257268154137285221199237182
Gender
 Male31.968.10.33462.437.60.53231.468.60.65053.346.70.88555.244.80.538
 Female36.963.165.634.433.666.454.046.058.441.6
Age
 ≤6034.565.50.60064.735.30.57134.066.00.39254.046.00.83752.647.40.154
 >6032.068.062.137.930.269.853.047.059.340.7
Tumor size
 ≤5 cm33.666.40.98264.835.20.66833.166.90.80750.649.40.40057.043.00.933
 >5 cm33.566.562.837.231.968.154.745.356.643.4
Pathological type
 Tubular adenocarcinoma32.267.80.39362.837.20.88931.368.70.41454.645.40.50755.644.40.853
 Signet ring cell carcinoma36.863.265.234.830.469.647.852.256.543.5
 Others43.856.366.733.342.457.645.554.560.639.4
Differentiation
 Well to moderate37.662.40.19161.138.90.50134.465.60.45857.742.30.15254.545.50.646
 Poor31.168.964.435.630.969.150.549.556.843.2
TNM stage
 I/II29.670.40.06562.937.10.71029.470.60.18352.048.00.61858.541.50.354
 III/IV38.461.664.635.435.464.654.445.654.145.9
Lymph-vascular invasion
 Absent33.067.00.84960.739.30.49931.668.40.80049.650.40.44657.842.20.829
 Present34.066.064.235.832.967.153.746.356.643.4
Neural invasion
 Absent32.867.20.69962.637.40.79433.067.00.84850.050.00.30560.040.00.215
 Present34.765.363.836.232.167.955.045.054.145.9
Radical surgery
 Yes33.266.80.99563.736.30.41531.968.10.91053.546.50.99156.243.80.827
 No33.366.753.346.733.366.753.346.753.346.7
Chemotherapy
 No30.269.80.05659.940.10.02828.771.30.02656.443.60.06955.144.90.530
 Yes39.860.270.729.339.360.747.152.958.341.7